KIT to help Korean drugs gain U.S. FDA approval

The Korea Institute of Toxicology (KIT), a world-class non-clinical contract research organization (CRO) located in Daejeon, is planning to support pharmaceutical companies’ advancement into the U.S. market as the organization received the "voluntary action indicated (VAI) from the U.S. Food and Drug Administration last month.

VAI means an U.S. FDA inspector found objections, but none were s...